日本消化器病学会アーカイブシステム

セッション	検索結果は2件です。 IF2-3-I (Keynote lecture) EASL/AASLD Guidelines Jordi Bruix（Hospital Clinic.Liver Unit BCLC Group） The incidence of Hepatocellular carcinoma （HCC） has increased in several countries during the last dec－ades and this has increased the attention paid to the diagnosis and management of the cancer． HCC... 第94回日本消化器病学会総会＞ IF2-3-II (Keynote lecture) Evidence-based clinical practice guidelines for hepatocellular carcinoma in Japan: the J-HCC Guidelines Norihiro Kokudo（Department of SurgeryHepato-Biliary-Pancreatic Surgery DivisionArtificial Organ and Transplantation DivisionUniversity of Tokyo^1） The “Clinical practice guidelines for hepatocellular carcinoma （HCC）the first evidence-based guidelinesfor the treatment of HCC in Japan， were compiled by an expert panel supported by the Japanese Mi... 第94回日本消化器病学会総会＞

セッション

検索結果は2件です。

IF2-3-I (Keynote lecture) EASL/AASLD Guidelines: Jordi Bruix（Hospital Clinic.Liver Unit BCLC Group）
The incidence of Hepatocellular carcinoma （HCC） has increased in several countries during the last dec－ades and this has increased the attention paid to the diagnosis and management of the cancer． HCC...
第94回日本消化器病学会総会＞
IF2-3-II (Keynote lecture) Evidence-based clinical practice guidelines for hepatocellular carcinoma in Japan: the J-HCC Guidelines: Norihiro Kokudo（Department of SurgeryHepato-Biliary-Pancreatic Surgery DivisionArtificial Organ and Transplantation DivisionUniversity of Tokyo^1）
The “Clinical practice guidelines for hepatocellular carcinoma （HCC）the first evidence-based guidelinesfor the treatment of HCC in Japan， were compiled by an expert panel supported by the Japanese Mi...
第94回日本消化器病学会総会＞